At the time of writing, Resmed Inc [RMD] stock is trading at $283.28, up 0.68%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RMD shares have gain 3.49% over the last week, with a monthly amount glided 1.37%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Resmed Inc [NYSE: RMD] stock has seen the most recent analyst activity on September 18, 2025, when Citigroup initiated its Buy rating and assigned the stock a price target of $330. Previously, CLSA upgraded its rating to Outperform on September 02, 2025. On July 15, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $294 on the stock. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $280 on March 19, 2025. Morgan Stanley initiated its recommendation with a Overweight. In a note dated January 10, 2025, Piper Sandler initiated an Neutral rating and provided a target price of $252 on this stock.
For the past year, the stock price of Resmed Inc fluctuated between $199.92 and $293.81. Currently, Wall Street analysts expect the stock to reach $275 within the next 12 months. Resmed Inc [NYSE: RMD] shares were valued at $283.28 at the most recent close of the market. An investor can expect a potential drop of -2.92% based on the average RMD price forecast.
Analyzing the RMD fundamentals
According to Resmed Inc [NYSE:RMD], the company’s sales were 5.15B for trailing twelve months, which represents an 10.20% jump. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.33%, Pretax Profit Margin comes in at 0.33%, and Net Profit Margin reading is 0.27%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.26 and Total Capital is 0.24. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 280.86 points at the first support level, and at 278.43 for the second support level. However, for the 1st resistance point, the stock is sitting at 284.85, and for the 2nd resistance point, it is at 286.41.
Ratios To Look Out For
It is important to note that Resmed Inc [NYSE:RMD] has a current ratio of 3.44. As well, the Quick Ratio is 2.53, while the Cash Ratio is 1.19. Considering the valuation of this stock, the price to sales ratio is 8.03, the price to book ratio is 6.95 and price to earnings (TTM) ratio is 29.79.
Transactions by insiders
Recent insider trading involved Farrell Michael J., Officer, that happened on Oct 07 ’25 when 8009.0 shares were purchased. Former Officer, Ghoshal Kaushik completed a deal on Oct 07 ’25 to buy 4876.0 shares. Meanwhile, Chief Financial Officer Sandercock Brett sold 3000.0 shares on Oct 01 ’25.
